Join Kirill Soldatov at BVMA Symposium 2026
Kirill Soldatov, Head of Process Improvement at PSI CRO, will share how agentic AI is transforming clinical trial execution, organizational design, and operational decision-making. Meet the PSI team in Munich to discuss how sponsors can assess AI readiness and prioritize operational execution.
From Coordinators to AI Conductors [Oral Presentation]
20 November 2026 · 16:20–16:40
Learn how sponsors can identify practical, operationally viable AI transformation by focusing on readiness, process codification, and governance.
As clinical development teams adopt AI-enabled trial operations, the key question becomes: Does your organization have the operational structure to leverage AI in real phase 2–3 studies? PSI, a global CRO operating in 58 countries since 1995, has centered its AI transformation on operational execution, workflow orchestration, and decision support rooted in real-world delivery.
Kirill Soldatov will explore how agentic AI is advancing from simple productivity tools to supporting complex operational decisions. He’ll share how PSI’s AI-first frameworks – like INTELIA™, our trial management suite, and SYNETIC™, our AI site intelligence platform with data from over 500,000 institutions – empower sponsors to navigate global trial complexity and timeline challenges.
Attending team members:
- Kirill Soldatov
Head of Process Improvement
- Michael Sommer
Senior Director, Business Development
Related Resources:
Blog: The site economy: Understanding site decision-making
Webinar: Agentic AI in Clinical Trials — Swiss Biotech Day Panel
White Paper: The operational reality of agentic AI in phase 2-3 trials
